Christopher Blay
Clinical Research Coordinator
Psychiatry
School of Medicine

Publications (3)

Top publication keywords:
Survival RateRectumEsophagogastric JunctionRadiotherapy Planning, Computer-AssistedPeritoneal NeoplasmsAdenocarcinomaUncertaintyCone-Beam Computed TomographyReceptor, ErbB-2Prostatic NeoplasmsGene AmplificationStomach NeoplasmsBrain NeoplasmsRadiotherapy, Intensity-ModulatedDisease-Free Survival

• Development of the Clinical High Risk for Psychosis Services Fidelity Scale (CHRPS-FS) for Team-Based Care.
  Psychiatric services (Washington, D.C.) 2025 Savill M, Banks LM, Sepulveda BT, Ho S, Tryon VL, Nye KE, Blay C, Carlson MM, Asbun AF, Ereshefsky S, LaCross KL, Hayes SL, Niendam TA, Addington DE
• Quantification of dose uncertainties in cumulated dose estimation compared to planned dose in prostate IMRT.
  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2016 Nassef M, Simon A, Cazoulat G, Duménil A, Blay C, Lafond C, Acosta O, Balosso J, Haigron P, de Crevoisier R
• Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma.
  Acta oncologica (Stockholm, Sweden) 2015 Blay C, Chiforeanu DC, Boucher E, Cabillic F, Desgrippes R, Leconte B, Perrin C, Manfredi S, Audrain O, Meunier B, Edeline J